Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
CT011
i
Other names:
CT011, Y035, CAR-GPC3 T, CT 011, Y 035, CT-011, Y-035
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
CARsgen
Drug class:
GPC-3-targeted CAR-T immunotherapy
Related drugs:
‹
CT017 (1)
ADI-002 (0)
AGAR T cells (0)
AZD7003 (0)
B010-A (0)
BOXR1030 (0)
CT0180 (0)
CT0181 (0)
EU307 (0)
GAP T cells (0)
GLYCAR T cells (0)
GPC3-CAR and IL15 plus IL21 (0)
GPC3-CAR-T Cells (0)
GPC3-CAR-T cells (0)
GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T cells (0)
IM83 (0)
LB2101 (0)
Mesothelin/GPC3/GUCY2C-CAR-T (0)
NIB102 (0)
Ori-C101 (0)
TAI-GPC3-CART cells (0)
CT017 (1)
ADI-002 (0)
AGAR T cells (0)
AZD7003 (0)
B010-A (0)
BOXR1030 (0)
CT0180 (0)
CT0181 (0)
EU307 (0)
GAP T cells (0)
GLYCAR T cells (0)
GPC3-CAR and IL15 plus IL21 (0)
GPC3-CAR-T Cells (0)
GPC3-CAR-T cells (0)
GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T cells (0)
IM83 (0)
LB2101 (0)
Mesothelin/GPC3/GUCY2C-CAR-T (0)
NIB102 (0)
Ori-C101 (0)
TAI-GPC3-CART cells (0)
›
Associations
News
Trials
Filter by
Latest
3ms
CT011 Autologous CAR-T Cells in Patients With Hepatocellular Carcinoma at Risk of Recurrence After Surgical Resection (clinicaltrials.gov)
P1, N=30, Recruiting, CARsgen Therapeutics Co., Ltd.
3 months ago
New P1 trial • CAR T-Cell Therapy
|
CT011
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login